Effect of Astragaloside on Gene Expression of Coxsackie-Adenovirus Receptor in Viral Myocarditic Mice
YU Xiao-hua,ZHANG Xin-gang,WANG Shi-jun,ZHAO Gang,CHEN Rui-zhen,YANG Ying-zhen,LI Shuang-jie
DOI: https://doi.org/10.3969/j.issn.1003-515x.2005.03.012
2005-01-01
Abstract:Objective To investigate the effect of astragaloside on myocardial coxsackie-adenovirus receptor(CAR)gene expression, one of the active components of astragalus membranaceus,in coxsackievirus B(CVB_3)inducing murine myocarditis model. Methods One hundred Balb/c mice were randomly divided into 6 groups.Group A[n=10,treated with carboxymethycellulose(CMC) 0.1 mL,intragastric administration(ig),for 1 week]was served as normal controls and group B(n=10,treated with 9% astragaloside 0.1 mL,ig, for 1 week)as treatment controls. The other eighty infected animals treated with CMC and 1%,3%,9% astragaloside 0.1 mL,ig,for 1 week(n=20 in each group)were served as group C,D,E,F. The mice were killed and their hearts were removed after 14 days. The expression levels of CAR mRNA in myocardium were examined by RT-PCR.Results The mortality was significantly reduced in 9% astragaloside treated infected animals that was 10% vs 45% in group C(χ2=6.14 P0.05). In uninfected animals, 9% astragaloside did not cause any death. The expression levels of CAR mRNA and myocardial histopathologic scores were significantly lower in group F than those in group C. However, the CAR expression and myocardial histopathologic scores were not affected by 1% and 3% astragaloside.Conclusions Findings showed that 9% astragaloside could inhibit CAR expression, improve survival rate and reduce myocardial lesion. It may be an effective drug for viral myocarditis.